These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31524211)

  • 21. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance.
    Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R
    Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
    J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy.
    Zhang Z; Niu N; Gao X; Han F; Chen Z; Li S; Li J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():335-345. PubMed ID: 30316080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells.
    Du G; Lin H; Wang M; Zhang S; Wu X; Lu L; Ji L; Yu L
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):277-87. PubMed ID: 19466611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H
    Du B; Ding X; Wang H; Du Q; Xu T; Huang J; Zhou J; Cheng G
    J Mater Chem B; 2019 Aug; 7(31):4784-4793. PubMed ID: 31389949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases.
    Daruwalla J; Greish K; Malcontenti-Wilson C; Muralidharan V; Maeda H; Christophi C
    Surgery; 2015 Jul; 158(1):236-47. PubMed ID: 25999256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable MnFe-hydroxide nanocapsules to enable multi-therapeutics delivery and hypoxia-modulated tumor treatment.
    Liao L; Cen D; Fu Y; Liu B; Fang C; Wang Y; Cai X; Li X; Wu HB; Han G
    J Mater Chem B; 2020 May; 8(17):3929-3938. PubMed ID: 32232281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
    Jin Y; Zhang Z; Zhao T; Liu X; Jian L
    J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
    Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
    Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
    Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.
    Xu W; Han M; Diao Y; Pan T; Ge W; Liu H; He H; Jiang H; Zheng S; Zhang S; Gao J; Wei Q
    Discov Med; 2014 Oct; 18(99):169-77. PubMed ID: 25336030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential Intercellular Delivery Nanosystem for Enhancing ROS-Induced Antitumor Therapy.
    Wang B; Zhang H; An J; Zhang Y; Sun L; Jin Y; Shi J; Li M; Zhang H; Zhang Z
    Nano Lett; 2019 Jun; 19(6):3505-3518. PubMed ID: 31034238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species.
    Wartenberg M; Ling FC; Müschen M; Klein F; Acker H; Gassmann M; Petrat K; Pütz V; Hescheler J; Sauer H
    FASEB J; 2003 Mar; 17(3):503-5. PubMed ID: 12514119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing.
    Ngoune R; Contini C; Hoffmann MM; von Elverfeldt D; Winkler K; Putz G
    Curr Drug Deliv; 2018; 15(9):1261-1270. PubMed ID: 29779479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.